Bladder Cancer

Latest News

BCAN announces awardee of its first-ever bladder cancer career development award
BCAN announces awardee of its first-ever bladder cancer career development award

March 20th 2023

Roger Li, MD, Moffit Cancer Center, was awarded the grant to study the novel oncolytic virus drug CG0070 in patients with intermediate-risk non–muscle-invasive bladder cancer.

blurred photo of clinic hallway
Western region of the US is associated with higher costs for radical cystectomy

March 14th 2023

FDA fast tracks treatment for immune checkpoint inhibitor–resistant urothelial carcinoma
FDA fast tracks treatment for immune checkpoint inhibitor–resistant urothelial carcinoma

March 13th 2023

Dr. Grivas discusses real-world study of frontline avelumab maintenance in urothelial carcinoma
Dr. Grivas discusses real-world study of frontline avelumab maintenance in urothelial carcinoma

March 10th 2023

clinical rendition of bladder cancer on an x-ray
Gemcitabine plus docetaxel may be a feasible alternative to first-line BCG in NMIBC

March 3rd 2023

Video Series
Video Interviews
Podcasts

More News

© 2023 MJH Life Sciences

All rights reserved.